Coastal Contacts Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Coastal Contacts Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7355
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Coastal Contacts Inc (Coastal Contacts), a subsidiary of Essilor International Compagnie Generale d’Optique SA, is an online retailer that markets eye care products. The company provides products such as eyeglasses, contact lenses, sunglasses and vision care accessories, among others. It offers contact lenses such as daily wear colour lenses, weekly wear contact lenses, monthly wear contact lenses, and others. Coastal Contacts provides its glasses different shapes made up of metal, stainless steel, titanium, plastics, and others. The company offers its products under the brands of Bausch+Lomb, Hugo Boss, Proclear, Spy, Dsquared, Ray-Ban, Skechers, Oakley, and others. It provides its products through its network of distribution, manufacturing, business facilities, and others. Coastal Contacts is headquartered in Vancouver, British Columbia, Canada.

Coastal Contacts Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Coastal Contacts Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Coastal Contacts Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Coastal Contacts Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Coastal Contacts Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Coastal Contacts Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Coastal Contacts Inc, Medical Equipment, Deal Details 10
Partnerships 10
Coastal Contacts Enters Into Distribution Agreement With Oakley 10
Equity Offering 11
Coastal Contacts Completes Public Offering Of Shares For US$20 Million 11
Acquisition 13
Essilor International Completes Acquisition Of Coastal Contacts For US$387.5 Million 13
Coastal Contacts Inc – Key Competitors 15
Coastal Contacts Inc – Key Employees 16
Coastal Contacts Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Coastal Contacts Inc, Medical Equipment, Key Facts 2
Coastal Contacts Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Coastal Contacts Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Coastal Contacts Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Coastal Contacts Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Coastal Contacts Inc, Deals By Market, 2012 to YTD 2018 8
Coastal Contacts Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Coastal Contacts Enters Into Distribution Agreement With Oakley 10
Coastal Contacts Completes Public Offering Of Shares For US$20 Million 11
Essilor International Completes Acquisition Of Coastal Contacts For US$387.5 Million 13
Coastal Contacts Inc, Key Competitors 15
Coastal Contacts Inc, Key Employees 16

List of Figures
Coastal Contacts Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Coastal Contacts Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Coastal Contacts Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Coastal Contacts Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Coastal Contacts Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Coastal Contacts Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Coastal Contacts Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Coastal Contacts Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Coastal Contacts Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • S.C. Hidroelectrica SA:企業の戦略的SWOT分析
    S.C. Hidroelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • Chembio Diagnostic, Inc. (CEMI)-医療機器分野:企業M&A・提携分析
    Summary Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes P …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Curie Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biolo …
  • AMAG Pharmaceuticals Inc (AMAG)-製薬・医療分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Sonoco Products Company:企業の戦略・SWOT・財務情報
    Sonoco Products Company - Strategy, SWOT and Corporate Finance Report Summary Sonoco Products Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Next Plc:企業の戦略・SWOT・財務情報
    Next Plc - Strategy, SWOT and Corporate Finance Report Summary Next Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Qinetiq Group Plc:企業の戦略・SWOT・財務分析
    Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report Summary Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mologen AG:企業のM&A・事業提携・投資動向
    Mologen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mologen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Vericel Corp (VCEL):医療機器:M&Aディール及び事業提携情報
    Summary Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn domains. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts fo …
  • Abcodia Ltd:企業の製品パイプライン分析2018
    Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diag …
  • Profectus BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Profectus BioSciences Inc (Profectus), formerly Maryland Biotherapeutics Inc is a clinical-stage vaccine development company that designs and develops vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products comprise genevax therapeutic vaccine …
  • Isagen SA ESP:企業の発電所・SWOT分析2018
    Isagen SA ESP - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Sandoz International GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • GTx Inc (GTXI):製薬・医療:M&Aディール及び事業提携情報
    Summary GTx Inc (GTx) is a biopharmaceutical company that discovers, develops and commercializes novel targeted hormonal therapies. It develops small molecules that targets hormone pathways for the treatment of various cancers including breast and prostate cancer; and other serious medical condition …
  • PNM Resources, Inc. (PNM)-エネルギー分野:企業M&A・提携分析
    Summary PNM Resources, Inc. (PNMR) is an investor-owned holding company that provides electricity and electric services in New Mexico and Texas. It has interests in PNM and TNMP utilities. PNM produces electricity from coal, natural gas, nuclear, solar, wind, and geothermal sources; transmits and di …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆